INDOCO REMEDIES LTD.
Quaterly Results
Particulars | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | Audited | UnAudited |
Net Sales | 4496.4 | 4594.2 | 4817.3 | 4265 |
Total Expenditure | 4007.7 | 3965.2 | 4103.6 | 3653.3 |
PBIDT (Excl OI) | 488.7 | 629 | 713.7 | 611.7 |
Other Income | 26.6 | 23.5 | 44.3 | 4.1 |
Operating Profit | 515.3 | 652.5 | 758.00 | 615.8 |
Interest | 120.5 | 100.7 | 81.1 | 77.9 |
Exceptional Items | 197.3 | -82 | NA | NA |
PBDT | 592.1 | 469.8 | 676.90 | 537.9 |
Depreciation | 262.3 | 243.5 | 214.1 | 198.8 |
Profit Before Tax | 329.8 | 226.3 | 462.80 | 339.1 |
Tax | 109.5 | 70.7 | 110.4 | 97.3 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 220.3 | 155.6 | 352.40 | 241.8 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 220.3 | 155.6 | 352.40 | 241.8 |
Minority Interest | 6.7 | 7.4 | -1.6 | 2.1 |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 227 | 163 | 350.8 | 243.9 |
Equity Capital | 184.4 | 184.3 | 184.3 | 184.3 |
Face Value (IN RS) | 2 | 2 | 2 | 2 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 2.46 | 1.76 | 3.80 | 2.64 |
Calculated EPS (Annualised) | 9.84 | 7.07 | 15.22 | 10.58 |
No of Public Share Holdings | 38051201 | 38019351 | 38019351 | 38030687 |
% of Public Share Holdings | 41.28 | 41.26 | 41.26 | 41.27 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 10.86 | 13.69 | 14.81 | 14.34 |
PBIDTM% | 11.46 | 14.20 | 15.73 | 14.43 |
PBDTM% | 13.16 | 10.22 | 14.05 | 12.61 |
PBTM% | 7.33 | 4.92 | 9.60 | 7.95 |
PATM% | 4.89 | 3.38 | 7.31 | 5.66 |
"; | Notes | Notes | Notes | Notes |